Real-life effects of adding weekly subcutaneous semaglutide to insulin for the treatment of type 2 diabetes mellitus-Reference-Cited by-同舟云学术

Real-life effects of adding weekly subcutaneous semaglutide to insulin for the treatment of type 2 diabetes mellitus

Published:2022-11 Issue:9 Volume:222 Page:516-522
ISSN:2254-8874
Container-title:Revista Clínica Española (English Edition)
language:en
Short-container-title:Revista Clínica Española (English Edition)

Author:

Ares-Blanco J.,Pujante-Alarcón P.,Lambert C.,Morales-Sánchez P.,Delgado-Álvarez E.,Menéndez-Torre E.L.

Publisher

Elsevier BV

Subject

General Medicine

Reference21 articles.

1. Standards of Medical Care in Diabetes-2022 Abridged for Primary Care Providers. Clin Diabetes [Internet]. 2021 Dec 17 [accessed 30 Dec 2021]; Available from: https://diabetesjournals.org/clinical/article/doi/10.2337/cd22-as01/139035/Standards-of-Medical-Care-in-Diabetes-2022.

2. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients;Riddle;Diabetes Care [Internet].,2003

3. A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes;Rosenstock;Diabetologia [Internet].,2008

4. Insulin initiation in primary care for patients with type 2 diabetes: 3-year follow-up study;Dale;Prim Care Diabetes [Internet].,2010

5. Glycemic control among patients with type 2 diabetes who initiate basal insulin: a retrospective cohort study;Curtis;J Med Econ.,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Semaglutide for the management of diabesity: The real-world experience;World Journal of Methodology;2024-09-20